Over the trailing 12 months, TCMD insiders sold $2.14 million worth of shares (75.69K shares) in open-market trades, with no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sheri Louise Dodd | Chief Executive Officer | 232,907 | 0 | 232,907 | 21.8% | 12 Aug, 2026 |
| 2 | Daniel L. Reuvers | President And Ceo | 146,442 | 0 | 146,442 | 13.7% | 13 Mar, 2025 |
| 3 | Elaine M. Birkemeyer | Chief Financial Officer | 130,188 | 0 | 130,188 | 12.2% | 13 May, 2026 |
| 4 | Kristie Burns | Sr. Vp Mktg Clinical Affairs | 82,581 | 0 | 82,581 | 7.7% | 26 Feb, 2026 |
| 5 | Raymond Huggenberger | Director | 62,841 | 0 | 62,841 | 5.9% | 08 May, 2026 |
| 6 | David Brent Shafer | Director | 55,343 | 0 | 55,343 | 5.2% | 08 May, 2026 |
| 7 | Valerie L. Asbury | Director | 55,343 | 0 | 55,343 | 5.2% | 08 May, 2026 |
| 8 | William W Burke | Director | 50,041 | 0 | 50,041 | 4.7% | 09 Nov, 2026 |
| 9 | Brent Moen | Chief Financial Officer | 48,760 | 0 | 48,760 | 4.6% | 03 Mar, 2023 |
| 10 | Carmen B Volkart | Director | 44,219 | 0 | 44,219 | 4.1% | 08 May, 2026 |
| 11 | Boyd Vindell Washington | Director | 41,768 | 0 | 41,768 | 3.9% | 08 May, 2026 |
| 12 | Sherri Lee Ferstler | Senior Vp, Sales | 38,764 | 0 | 38,764 | 3.6% | 14 Aug, 2024 |
| 13 | Eric Pauls | Senior Vp, Sales | 29,498 | 0 | 29,498 | 2.8% | 10 May, 2023 |
| 14 | Laura G. King | Director | 20,769 | 0 | 20,769 | 1.9% | 05 Nov, 2026 |
| 15 | Deepti Jain | Director | 15,448 | 0 | 15,448 | 1.4% | 11 May, 2022 |
| 16 | Andrea Pearson | Director | 7,373 | 0 | 7,373 | 0.7% | 08 May, 2026 |
| 17 | Stephen A. Kiewiet | Chief Operating Officer | 6,438 | 0 | 6,438 | 0.6% | 06 Nov, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 04 Nov, 2026 | William W Burke | Director | Disposed S | 5,000 | $27.00 | $135.00K | 50,041 | Direct |
| 04 Nov, 2026 | Stephen A. Kiewiet | Chief Operating Officer | Acquired A | 6,438 | $0.00 | $0 | 6,438 | Direct |
| 03 Nov, 2026 | Laura G. King | Director | Disposed S | 4,800 | $25.00 | $120.00K | 20,769 | Direct |
| 10 Aug, 2026 | Sheri Louise Dodd | Chief Executive Officer | Disposed S | 10,978 | $29.44 | $323.24K | 232,907 | Direct |
| 11 May, 2026 | Elaine M. Birkemeyer | Chief Financial Officer | Disposed S | 4,631 | $24.49 | $113.40K | 130,188 | Direct |
| 06 May, 2026 | William W Burke | Director | Acquired A | 6,521 | $0.00 | $0 | 55,041 | Direct |
| 06 May, 2026 | David Brent Shafer | Director | Acquired A | 6,521 | $0.00 | $0 | 55,343 | Direct |
| 06 May, 2026 | Boyd Vindell Washington | Director | Acquired A | 6,521 | $0.00 | $0 | 41,768 | Direct |
| 06 May, 2026 | Valerie L. Asbury | Director | Acquired A | 6,521 | $0.00 | $0 | 55,343 | Direct |
| 06 May, 2026 | Laura G. King | Director | Acquired A | 6,521 | $0.00 | $0 | 25,569 | Direct |
| 06 May, 2026 | Raymond Huggenberger | Director | Acquired A | 6,521 | $0.00 | $0 | 62,841 | Direct |
| 06 May, 2026 | Carmen B Volkart | Director | Acquired A | 6,521 | $0.00 | $0 | 44,219 | Direct |
| 06 May, 2026 | Andrea Pearson | Director | Acquired A | 6,521 | $0.00 | $0 | 7,373 | Direct |
| 09 Mar, 2026 | Andrea Pearson | Director | Acquired A | 852 | $0.00 | $0 | 852 | Direct |
| 24 Feb, 2026 | Elaine M. Birkemeyer | Chief Financial Officer | Disposed S | 7,701 | $28.94 | $222.88K | 134,819 | Direct |
| 24 Feb, 2026 | Kristie Burns | Sr. Vp Mktg Clinical Affairs | Disposed S | 6,246 | $28.94 | $180.76K | 82,581 | Direct |
| 24 Feb, 2026 | Sheri Louise Dodd | Chief Executive Officer | Disposed S | 10,993 | $28.94 | $318.14K | 243,885 | Direct |
| 20 Feb, 2026 | Kristie Burns | Sr. Vp Mktg Clinical Affairs | Acquired A | 3,490 | $0.00 | $0 | 82,085 | Direct |
| 20 Feb, 2026 | Sheri Louise Dodd | Chief Executive Officer | Acquired A | 19,751 | $0.00 | $0 | 241,902 | Direct |
| 20 Feb, 2026 | Elaine M. Birkemeyer | Chief Financial Officer | Acquired A | 3,579 | $0.00 | $0 | 125,698 | Direct |